Circulation. Heart failure · 2025
Ca2+ Cycling Alteration in a Porcine Model of Right Ventricular Dysfunction.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Antigny Fabrice, Luo Rui, Perrier Romain, Masson Bastien, Fadel Guillaume, Ruffenach Grégoire, Saint-Martin Willer Anaïs, Akamkam Ali, Grynblat Julien, Jaïs Xavier, Le Pavec Jerôme, Dang Van Simon, Brunet Dorothée, Lefebvre Florence, Gérard Garance, Domenichini Séverine, Boët Angèle, Guihaire Julien, Gomez Ana-Maria, Montani David, Benitah Jean-Pierre, Humbert Marc, Mercier Olaf, Sabourin Jessica
Аннотация
BACKGROUND: Pulmonary hypertension is a severe disease with high mortality rates due to right ventricular (RV) failure. The molecular and cellular processes involved in RV remodeling, including Ca2+ handling, remain elusive due to the lack of relevant animal models. In this study, we aim to understand better the pathophysiological mechanisms involved in RV failure.
METHODS: We used the chronic thromboembolic pulmonary hypertension (CTEPH) pig model, which leads to progressive RV hypertrophy and dysfunction. Cellular, molecular unbiased global transcriptional profiling and biochemical analyses were performed on RV cardiomyocytes from CTEPH and Sham-operated pigs.
RESULTS: CTEPH pigs replicated the hemodynamics and histological changes of human CTEPH features. Transcriptome analysis in Sham and CTEPH pigs revealed molecular RV remodeling close to human patients with pulmonary arterial hypertension with decompensated RV function and notably identified changes in genes involved in Ca2+ signaling. At the cellular level, CTEPH myocytes presented reduced L-type Ca2+ current in association with reduced mRNA of CACNA1C. Furthermore, CTEPH myocytes showed lower [Ca2+]i transients, decreased sarcoplasmic reticulum Ca2+ content, and decreased cell shortening, related to reduced SERCA2a (Sarco/endoplasmic reticulum Ca2+-ATPase isoform 2a) protein expression. Moreover, CTEPH cardiomyocytes exhibited reduced Ca2+ spark occurrence, which relied on smaller RyR2 (ryanodine receptor 2) clusters and T-tubule disorganization. Finally, these alterations in Ca2+ homeostasis were also associated with an increased store-operated Ca2+ entry and the de novo expression of the Ca2+ sensor protein STIM1L (stromal interaction molecule 1 long isoform) in CTEPH myocytes as well as in RV from human patients with pulmonary arterial hypertension.
CONCLUSIONS: Our data reveal cellular Ca2+ cycling remodeling that participates in the pathogenesis of RV dysfunction and may constitute therapeutic targets to limit the development of RV dysfunction.
METHODS: We used the chronic thromboembolic pulmonary hypertension (CTEPH) pig model, which leads to progressive RV hypertrophy and dysfunction. Cellular, molecular unbiased global transcriptional profiling and biochemical analyses were performed on RV cardiomyocytes from CTEPH and Sham-operated pigs.
RESULTS: CTEPH pigs replicated the hemodynamics and histological changes of human CTEPH features. Transcriptome analysis in Sham and CTEPH pigs revealed molecular RV remodeling close to human patients with pulmonary arterial hypertension with decompensated RV function and notably identified changes in genes involved in Ca2+ signaling. At the cellular level, CTEPH myocytes presented reduced L-type Ca2+ current in association with reduced mRNA of CACNA1C. Furthermore, CTEPH myocytes showed lower [Ca2+]i transients, decreased sarcoplasmic reticulum Ca2+ content, and decreased cell shortening, related to reduced SERCA2a (Sarco/endoplasmic reticulum Ca2+-ATPase isoform 2a) protein expression. Moreover, CTEPH cardiomyocytes exhibited reduced Ca2+ spark occurrence, which relied on smaller RyR2 (ryanodine receptor 2) clusters and T-tubule disorganization. Finally, these alterations in Ca2+ homeostasis were also associated with an increased store-operated Ca2+ entry and the de novo expression of the Ca2+ sensor protein STIM1L (stromal interaction molecule 1 long isoform) in CTEPH myocytes as well as in RV from human patients with pulmonary arterial hypertension.
CONCLUSIONS: Our data reveal cellular Ca2+ cycling remodeling that participates in the pathogenesis of RV dysfunction and may constitute therapeutic targets to limit the development of RV dysfunction.